healthprofessionalradio, Author at Health Professional Radio

The Health News – 13 March 2014

13 March 2014

No comments

Overview

In NSW, the state health minister has not ruled out private operation of a new Maitland hospital being built at Metford. There is ongoing concern as to how the new facility will be managed and if it will eventually be operated by a private party.

In Victoria, a Macedon Ranges community health care provider has revealed long-term federal funding cuts have forced the organisation to rethink their operations.

In the ACT, the acting director-general of health Dr Paul Kelly yesterday announced the commencement of the Health Food and Drink Choices Policy for ACT Health.

Advances In Medical Technology

13 March 2014

No comments

Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury discusses the advances in medical technology. He also touches on the humble beginnings of medical discoveries.

Gene Patches: Classified As Drugs

13 March 2014

No comments

Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury discusses why gene patches are classified as drugs and tested in the same way as conventional drugs.

The Changing Face Of Childbirth

13 March 2014

No comments

Presenter: Neal Howard
Guest: Roanna Rosewood
Guest Bio: Roanna Rosewood is the Operations Director of Human Rights in Childbirth, an international NGO, based in The Netherlands. Roanna works to clarify and advance the fundamental human rights of pregnant women. She is also an international award-winning birth empowerment speaker and the author of, “Cut, Stapled, & Mended: When One Woman Reclaimed Her Body and Gave Birth on Her Own Terms After Cesarean.” (Confluence Press, 2013).

Segment Overview
Roanna Rosewood reads from her book “Cut, Stapled, and Mended….” describing one of her childbirth experiences.

The Future Of Gene Patch Technology

13 March 2014

No comments

Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury tells his story. The future of gene patch technology is also touched upon.

Mis-information On Affordable Care Act?

13 March 2014

No comments

Presenter: Neal Howard
Guest: Dr. Mark Davis
Guest Bio: Mark Davis is the author of “Obamacare, Dead on Arrival, A Prescription for Disaster”, “Demons of Democracy”, “The Millenium Diet: The Practical Guide for Weight Loss”, and other books. He is Media consultant in health care and its politics, a journalist with hundreds of articles to his credit, President of Davis Book Reviews and Healthnets Review Services, a Physician, and former manager and or owner of numerous health facilities.

Segment Overview
Dr. Mark Davis discusses the mis-information of the Affordable Care Act.

The Health News – 12 March 2014

12 March 2014

No comments

Overview

A new report on Australia’s mental health system calls for changes in many areas as the system struggles to meet demand.

The federal government is unlikely to include changes to the Disability Support Pension in the pending May budget and will not lead to present recipients having their benefit reduced.

Thanks to a new study by Monash University, heart attack patients may soon be treated with drugs that have no side effects.

Affordable Care Act: Affordable Or Not?

12 March 2014

No comments

Presenter: Neal Howard
Guest: Dr. Mark Davis
Guest Bio: Mark Davis is the author of “Obamacare, Dead on Arrival, A Prescription for Disaster”, “Demons of Democracy”, “The Millenium Diet: The Practical Guide for Weight Loss”, and other books. He is Media consultant in health care and its politics, a journalist with hundreds of articles to his credit, President of Davis Book Reviews and Healthnets Review Services, a Physician, and former manager and or owner of numerous health facilities.

Segment Overview
Dr. Mark Davis discusses the huge increase in co-pays and the cost of drugs and services. He claims that the Affordable Care Act is not affordable at all.

The Health News – 11 March 2014

11 March 2014

No comments

Overview

In WA, a diagnostic services clinic, as well as a former Perth doctor, were found guilty of deceptive conduct for asserting that their treatments effectively detected breast cancer.

Queensland Health has confirmed that several cases of swine flu have been reported on Palm Island in the state’s north.

lso in QLD, the new 1.75m dollar hospital on the Gold Coast will undergo an intense review beginning this week.

The Health News – 10 March 2014

10 March 2014

No comments

Overview

Prime Minister Tony Abbott has said the Federal Government will maintain its promise to make eligibility requirements for the Commonwealth Seniors Health Card.

In NSW, a new trial will see paramedics take patients who call ambulances for trivial matters like toothaches to their local GP rather than a hospital.

For patients of kidney failure, being rendered motionless for hours at a time by dialysis treatment is an unpleasant experience. But details of a new treatment device, currently on trial in the United States, were released at a health conference in Melbourne last week, the device is being described as an “artificial kidney belt.”